sb 203580 has been researched along with 15-deoxy-delta(12,14)-prostaglandin j2 in 5 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (15-deoxy-delta(12,14)-prostaglandin j2) | Trials (15-deoxy-delta(12,14)-prostaglandin j2) | Recent Studies (post-2010) (15-deoxy-delta(12,14)-prostaglandin j2) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 564 | 1 | 93 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arditi, M; Bulut, Y; Equils, O; Faure, E; Thomas, L; Trushin, S | 1 |
| Finck, BN; Johnson, RW | 1 |
| Hong, JT; Jung, KM; Jung, SY; Lee, MK; Oh, JH; Oh, KW; Park, KS; Park, YH; Son, DJ; Song, YS; Yang, KH; Yun, YP | 1 |
| Chau, LY; Lee, TS; Tsai, HL | 1 |
| Cancedda, FD; Cancedda, R; Ulivi, V | 1 |
5 other study(ies) available for sb 203580 and 15-deoxy-delta(12,14)-prostaglandin j2
| Article | Year |
|---|---|
Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4.
Topics: Animals; Cell Line, Transformed; Chromones; Drosophila Proteins; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; HIV Long Terminal Repeat; Humans; Imidazoles; Interleukin-1; Lipopolysaccharides; Luciferases; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinases; Morpholines; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostaglandin D2; Pyridines; Receptors, Cell Surface; Signal Transduction; Toll-Like Receptor 4; Toll-Like Receptors; Transcriptional Activation | 2001 |
Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-alpha.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Culture Techniques; Cycloheximide; Dactinomycin; Enzyme Inhibitors; Homeostasis; Imidazoles; Immunologic Factors; Leptin; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mitogen-Activated Protein Kinases; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Prostaglandin D2; Protein Synthesis Inhibitors; Pyridines; RNA, Messenger; Tumor Necrosis Factor-alpha | 2002 |
Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Enzyme Activation; Imidazoles; Immunologic Factors; Mitogen-Activated Protein Kinases; Nerve Growth Factors; Neurites; Neurofilament Proteins; Neuropeptides; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Prostaglandin D2; Pyridines; Rats; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Transcription Factor AP-1; Transcription Factors | 2003 |
Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.
Topics: Animals; Anti-Inflammatory Agents; Biological Transport; Blotting, Western; Carbon Monoxide; Cell Nucleus; Cycloheximide; Enzyme Induction; Enzyme Inhibitors; Fluorescent Antibody Technique; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; I-kappa B Proteins; Imidazoles; Lipopolysaccharides; Macrophage Activation; Macrophages; Membrane Proteins; Mice; Microscopy, Confocal; Mitogen-Activated Protein Kinases; NF-kappa B; NF-kappa B p50 Subunit; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organometallic Compounds; p38 Mitogen-Activated Protein Kinases; Prostaglandin D2; Protein Synthesis Inhibitors; Pyridines; Tumor Necrosis Factor-alpha | 2003 |
15-deoxy-delta 12,14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation.
Topics: Acute-Phase Proteins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Cartilage; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Diclofenac; Dinoprostone; Down-Regulation; Enzyme Induction; Enzyme Repression; Imidazoles; Inflammation; Intramolecular Oxidoreductases; Lipocalin-2; Lipocalins; Lipopolysaccharides; Mice; NF-kappa B; Oncogene Proteins; Oxazoles; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; PPAR alpha; PPAR gamma; Prostaglandin D2; Prostaglandin-E Synthases; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Time Factors; Tyrosine | 2008 |